HIGH FOLATE RECEPTOR-ALPHA EXPRESSION

Clinical trials for HIGH FOLATE RECEPTOR-ALPHA EXPRESSION explained in plain language.

Never miss a new study

Get alerted when new HIGH FOLATE RECEPTOR-ALPHA EXPRESSION trials appear

Sign up with your email to follow new studies for HIGH FOLATE RECEPTOR-ALPHA EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to control Tough-to-Treat ovarian cancer

Disease control Recruiting now

This study is testing an experimental drug called mirvetuximab soravtansine for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The main goals are to find the best dosing schedule and to see how…

Matched conditions: HIGH FOLATE RECEPTOR-ALPHA EXPRESSION

Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

HIGH FOLATE RECEPTOR-ALPHA EXPRESSION

Get alerted when new HIGH FOLATE RECEPTOR-ALPHA EXPRESSION trials appear

New drug trial aims to control Tough-to-Treat ovarian cancer